Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Brean Murray Initiates DexCom at Buy

Juan Lopez , Benzinga Staff Writer  
January 17, 2012 7:22am   Comments
Share:

Brean Murray Carret & Company has initiated coverage on DexCom (NASDAQ: DXCM) with a Buy rating and $12.50 price target.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (DXCM)

Forecasting The Future: 11 Analyst Projections For DexCom
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
Stocks Rise Ahead Of Fed Meeting, Oil Jumps To $70: What's Moving Markets Wednesday?
Earnings Scheduled For July 30, 2025
Beyond The Numbers: 8 Analysts Discuss DexCom Stock
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes
View Comments and Join the Discussion!

Posted-In: Brean Murray Carret & CompanyPrice Target Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com